Michael Rowinski
About Michael Rowinski
Michael Rowinski is the Vice President and US Oncology Thoracic Franchise Lead at Bristol Myers Squibb, with over 25 years of experience in various leadership roles within the company.
Company
Michael Rowinski is currently employed at Bristol Myers Squibb (BMS), a global biopharmaceutical company known for its research and development of innovative medicines. He holds the position of Vice President, US Oncology Thoracic Franchise Lead.
Title
Michael Rowinski serves as the Vice President, US Oncology Thoracic Franchise Lead at Bristol Myers Squibb. In this role, he oversees the strategic direction and commercial execution of thoracic oncology products in the United States.
Education and Expertise
Michael Rowinski holds a Master of Science in International Marketing and a Bachelor of Science in Marketing, both from Saint Joseph's University. With over 25 years of experience at Bristol Myers Squibb, he has specialized in oncology, immunology, virology, and cardiovascular therapeutic areas. His expertise includes marketing, sales force productivity, and commercial strategy.
Background
Michael Rowinski has an extensive background at Bristol Myers Squibb, having served in various roles since 1998. His previous positions include Vice President, Neurology and GI Immunology Sales, Executive Director, Worldwide Commercial Lead for various cancers, US Commercial Lead for GI Tumors, and Director of US Immuno-Oncology Marketing. He has consistently played a significant role in the commercialization of key therapeutic products.
Achievements
Michael Rowinski has been instrumental in launching and managing high-impact marketing campaigns for oncology and immunology products. He has led teams responsible for the commercial success of products like Sprycel and Atripla. His leadership has driven organizational change and contributed to the development of commercial strategies for early-stage oncology assets.